A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

Clinical trial NCT06885424 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06885424
Sponsor: A2 Biotherapeutics Inc.
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Solid Tumor Cancer Solid Tumor, Unspecified, Adult Colorectal Carcinoma Colorectal Carcinoma (CRC)Non Small Cell Lung Cancer Small Cell Lung Cancer ( SCLC )Pancreatic Cancer NSCLC Mesothelioma Ovarian Cancer Ovarian Carcinoma Head and Neck (HNSCC)

Start date: 2025-07-31
Primary completion: 2030-03-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.